- Home
- SNN vs RDY Comparison
SNN vs RDY Comparison
Compare SNN & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNN
- RDY
- Stock Information
- Founded
- SNN 1856
- RDY 1984
- Country
- SNN United Kingdom
- RDY India
- Employees
- SNN N/A
- RDY N/A
- Industry
- SNN Industrial Specialties
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- SNN Health Care
- RDY Health Care
- Exchange
- SNN Nasdaq
- RDY Nasdaq
- Market Cap
- SNN 13.2B
- RDY 11.8B
- IPO Year
- SNN 1999
- RDY N/A
- Fundamental
- Price
- SNN $37.05
- RDY $14.82
- Analyst Decision
- SNN Hold
- RDY Strong Buy
- Analyst Count
- SNN 3
- RDY 2
- Target Price
- SNN $31.50
- RDY $16.95
- AVG Volume (30 Days)
- SNN 641.0K
- RDY 842.1K
- Earning Date
- SNN 10-30-2025
- RDY 11-04-2025
- Dividend Yield
- SNN 1.98%
- RDY 0.48%
- EPS Growth
- SNN 59.91
- RDY 2.20
- EPS
- SNN 0.56
- RDY 0.79
- Revenue
- SNN $5,944,000,000.00
- RDY $3,897,394,052.00
- Revenue This Year
- SNN $7.75
- RDY $7.33
- Revenue Next Year
- SNN $5.37
- RDY $1.96
- P/E Ratio
- SNN $66.38
- RDY $18.85
- Revenue Growth
- SNN 5.35
- RDY 15.86
- 52 Week Low
- SNN $23.69
- RDY $12.26
- 52 Week High
- SNN $38.79
- RDY $16.19
- Technical
- Relative Strength Index (RSI)
- SNN 52.68
- RDY 62.82
- Support Level
- SNN $37.10
- RDY $14.60
- Resistance Level
- SNN $37.64
- RDY $15.06
- Average True Range (ATR)
- SNN 0.40
- RDY 0.16
- MACD
- SNN -0.30
- RDY 0.06
- Stochastic Oscillator
- SNN 23.01
- RDY 75.25
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.